IPHA logo

Innate Pharma S.A.

IPHA
Healthcare|Biotechnology|FR
$1.44
+0.04 (+2.86%)
Cash / Share
$0.12
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

Innate Pharma Reports Third Quarter 2026 Business and Financial Update
Nov 5, 2026 · Business Wire
Innate Pharma: PACIFIC-9 Phase 3 Trial Readout Timing Updated to H1 2027
Oct 27, 2026 · Business Wire
Innate Pharma to Participate in the Stifel Healthcare Conference and Jefferies Global Healthcare Conference
Oct 21, 2026 · Business Wire
Innate Pharma Announces Conference Call for Third Quarter 2026 Business and Financial Update
Oct 20, 2026 · Business Wire
Innate Pharma Reports First Half 2026 Business Update and Financial Results
Sep 17, 2026 · Business Wire
Innate and Sobi Announce Partnership Is Now Effective Following Completion of Closing Conditions
Sep 16, 2026 · Business Wire
Innate Pharma Announces Conference Call and Webcast
Aug 14, 2026 · Business Wire
Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma
Aug 10, 2026 · PRNewsWire
Innate Pharma to Advance Lacutamab Towards Phase 3 Following Partnership With Sobi and Appoints New Chief Medical Officer
Aug 10, 2026 · Business Wire
Innate Pharma Enters Strategic Partnership With Sobi to License Lacutamab in T-cell Lymphoma
Aug 10, 2026 · Business Wire

SEC Filings (91)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 5, 20266-KForeign issuer reportDocumentIndex
Oct 27, 20266-KForeign issuer reportDocumentIndex
Oct 21, 20266-KForeign issuer reportDocumentIndex
Oct 20, 20266-KForeign issuer reportDocumentIndex
Sep 17, 20266-KForeign issuer reportDocumentIndex
Sep 17, 20266-KForeign issuer reportDocumentIndex
Sep 17, 20266-KForeign issuer reportDocumentIndex
Sep 10, 20266-KForeign issuer reportDocumentIndex
Sep 2, 20266-KForeign issuer reportDocumentIndex
Aug 19, 20266-KForeign issuer reportDocumentIndex
Aug 14, 20266-KForeign issuer reportDocumentIndex
Aug 10, 20266-KForeign issuer reportDocumentIndex
Jul 23, 20266-KForeign issuer reportDocumentIndex
Jul 21, 20266-KForeign issuer reportDocumentIndex
Jun 22, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 22, 20266-KForeign issuer reportDocumentIndex
May 19, 20266-KForeign issuer reportDocumentIndex
May 13, 20266-KForeign issuer reportDocumentIndex
May 12, 20266-KForeign issuer reportDocumentIndex
May 6, 20266-KForeign issuer reportDocumentIndex
Apr 23, 20266-KForeign issuer reportDocumentIndex
Apr 17, 20266-KForeign issuer reportDocumentIndex
Apr 13, 20266-KForeign issuer reportDocumentIndex
Apr 13, 20266-KForeign issuer reportDocumentIndex
Apr 10, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Apr 8, 20266-KForeign issuer reportDocumentIndex
Apr 3, 20266-KForeign issuer reportDocumentIndex
Apr 2, 20266-KForeign issuer reportDocumentIndex
Apr 1, 202620-FAnnual report (foreign)DocumentIndex
Mar 26, 20266-KForeign issuer reportDocumentIndex
Mar 19, 20266-KForeign issuer reportDocumentIndex
Mar 4, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 18, 20266-KForeign issuer reportDocumentIndex
Feb 6, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jan 7, 20266-KForeign issuer reportDocumentIndex
Dec 22, 20256-KForeign issuer reportDocumentIndex
Dec 11, 20256-KForeign issuer reportDocumentIndex
Nov 28, 20256-KForeign issuer reportDocumentIndex
Nov 17, 20256-KForeign issuer reportDocumentIndex
Nov 13, 20256-KForeign issuer reportDocumentIndex